Nairobi, Feb. 15 -- Auditor-General Nancy Gathungu has flagged the Pharmacy and Poisons Board (PPB) over what she terms the irregular appointment of a chief executive officer in an acting capacity.

Ms Gathungu said there was no evidence showing that the acting CEO was appointed by the PPB board in consultation with the Cabinet Secretary for Health.

"Review of available information indicated that the current chief executive officer was serving in an acting capacity. However, there was no evidence to confirm that the appointment in an acting capacity was made by the Board in consultation with the Cabinet Secretary of the Ministry of Health," she said in the audit report for the financial year ended June 30, 2025.

The Auditor-General note...